Intrinsic Value of S&P & Nasdaq Contact Us

Elutia Inc. ELUT NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
71/100
3/7 Pass
SharesGrow Intrinsic Value
$28.86
+2366.7%
Analyst Price Target
$8.88
+659%

Elutia Inc. (ELUT) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 5 Buy.

The consensus price target is $8.88 (low: $5.00, high: $10.50), representing an upside of 659% from the current price $1.17.

Analysts estimate Earnings Per Share (EPS) of $-1.83 and revenue of $0.03B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-1.86 vs est $-1.83 (missed -1.6%). 2025: actual $1.29 vs est $-0.48 (beat +368.8%). Analyst accuracy: 31%.

ELUT Stock — 12-Month Price Forecast

$8.88
▲ +658.97% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for Elutia Inc., the average price target is $8.88, with a high forecast of $10.50, and a low forecast of $5.00.
The average price target represents a +658.97% change from the last price of $1.17.
Highest Price Target
$10.50
Average Price Target
$8.88
Lowest Price Target
$5.00

ELUT Analyst Ratings

Buy
5
Ratings
5 Buy
Based on 5 analysts giving stock ratings to Elutia Inc. in the past 3 months
Rating breakdown
Buy
5 100%
100%
Buy
5 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — ELUT

31%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$1.86 vs Est –$1.83 ▼ 1.6% off
2025 Actual $1.29 vs Est –$0.48 ▲ 137.2% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.

Revenue Estimates — ELUT

72%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024 Actual $0.024B vs Est $0.025B ▼ 1.7% off
2025 Actual $0.012B vs Est $0.019B ▼ 53.7% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message